PG
ALXN

Pendal Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Pendal Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,609
Closed -$5.62M – 672
2021
Q2 		$5.62M Buy
30,609
+26,100
+579% +$4.48M 0.05% 134
2021
Q1 		$689K Buy
4,509
+1,267
+39% +$196K 0.01% 365
2020
Q4 		$506K Sell
3,242
-42,911
-93% -$5.51M 0.01% 373
2020
Q3 		$5.28M Sell
46,153
-3,093
-6% -$334K 0.06% 97
2020
Q2 		$5.53M Sell
49,246
-3,283
-6% -$349K 0.08% 100
2020
Q1 		$4.72M Sell
52,529
-13,218
-20% -$1.3M 0.08% 92
2019
Q4 		$7.11M Buy
65,747
+64,212
+4,183% +$6.87M 0.09% 102
2019
Q3 		$150K Buy
+1,535
New +$173K ﹤0.01% 423
2018
Q1 		– Sell
-23,636
Closed -$2.83M – 511
2017
Q4 		$2.83M Buy
23,636
+22,461
+1,912% +$2.74M 0.04% 197
2017
Q3 		$165K Buy
+1,175
New +$160K ﹤0.01% 432

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return